About

Leadership

Meet Our Leadership Team

Stephen L. Eck, MD, PhD

Stephen L. Eck, MD, PhD

President and CEO

Dr. Eck has over 15 years of leadership experience in the development of oncology drugs and related biomarkers. Prior to joining Aravive, he was Vice President of Oncology Medical Sciences at Astellas Pharma Global Development, Inc. (more…)

Ray Tabibiazar, MD

Ray Tabibiazar, MD

Chairman

Dr. Tabibiazar brings more than 12 years of leadership experience in the healthcare industry, including key executive positions within the biopharmaceutical industry, as well as diagnostics, healthcare IT, and venture capital. In addition to his role at Aravive, he is also the Managing Director of 526 Ventures, a life sciences strategic consulting company working with both public and private biopharmaceutical firms. (more…)

Vinay Shah

Vinay Shah

Chief Financial Officer

Mr. Shah brings more than 16 years of financial management experience in the medical device and biopharmaceutical industries. Before joining Aravive, Mr. Shah was Executive Director of Finance and Strategy Analytics for Pacira Pharmaceuticals Inc., a specialty pharmaceutical company. (more…)

Amato Giaccia, PhD

Amato Giaccia, PhD

Chief Scientific Officer

Dr. Giaccia is an internationally known cancer biologist and serial entrepreneur. In addition to his role as Chief Scientific Officer of Aravive Biologics, he is Professor of Radiation Oncology, Associate Chair for Research & Director of the Division of Radiation & Cancer Biology in the Department of Radiation Oncology at Stanford University School of Medicine. (more…)

Gail McIntyre, PhD, DABT

Gail McIntyre, PhD, DABT

Senior Vice President, Research & Development

Dr. McIntyre has more than 25 years of experience in the drug discovery and development industry. She has authored more than 30 regulatory submissions and is a board-certified toxicologist with extensive experience in moving compounds through lead optimization and clinical development onto the market. (more…)

Laura Bonifacio, PharmD, PhD

Laura Bonifacio, PharmD, PhD

Vice President, Clinical Programs

Dr. Bonifacio brings more than 7 years of experience in drug development to Aravive Biologics. She spent 4 years at Furiex Pharmaceuticals, Inc and was responsible for managing an 11-study clinical pharmacology program and preparing the Clinical Pharmacology Summary for a late stage GI program that is now on the market in the US and EU. (more…)

Stephen Burrows, PhD

Stephen Burrows, PhD

Vice President, Chemistry Manufacturing and Controls

Dr. Burrows has over 30 years of experience in the pharmaceutical and biopharmaceutical industries including discovery, drug development, process development, and manufacturing under cGMP. Companies he has worked for include Warner-Lambert/Parke-Davis, G.D. Searle, SmithKline Beecham, Lexin Pharmaceutical Corp., Regeneron, Medarex, Antex Biologics, Primedica Corp., Shire Biologics and Blue Sky Biotech. (more…)

David Prohaska

David Prohaska

Director, Preclinical Development

Mr. Prohaska has more than 19 years of experience in all aspects of preclinical drug development including the scientific, technical and operational aspects and on-site monitoring of non-GLP and GLP animal metabolism, pharmacokinetic, toxicology, genotoxicity, photosafety, safety pharmacology and carcinogenicity studies. (more…)

Danielle Malloy

Danielle Malloy

Director, Corporate Operations

Ms. Malloy is responsible for performing a variety of management and professional activities, including establishing and directing departments and functions across the organization with an emphasis on planning, operational efficiency and effectiveness, performance management and organizational development. Prior to joining the company, she served as Manager, Corporate Services & Corporate Compliance for FUJIFILM Diosynth Biotechnologies Texas, LLC, (formerly Kalon Biotherapeutics, LLC). (more…)